Viva Biotech (1873.HK) Announces 2023 Interim Results:Solid Growth in Main Business, Significant Rebound in Profitability : vimarsana.com

Viva Biotech (1873.HK) Announces 2023 Interim Results:Solid Growth in Main Business, Significant Rebound in Profitability

Viva Biotech (1873.HK) Announces 2023 Interim Results:Solid Growth in Main Business, Significant Rebound in Profitability

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Zhoupu , Zhejiang , China , United Kingdom , Canada , Shanghai , Hangzhou , Suzhou , Jiangsu , United States , Taiwan , France , Chengdu , Sichuan , Japan , Australia , Switzerland , Qiantang , Guangdong , Germany , America , Langhua Pharma , Cheney Mao , Viva Biotech Holdings , Temasek , Viva Biotech Holdings Group , Successful Exit Of Incubation Portfolio Companies , Our Computational Chemistry Department , Shanghai Supercomputing Center , Solid Growth , Main Business , Significant Rebound , Interim Results , Reporting Period , Highlight Capital , Increasing Number , Langhua Pharmaceutical , Viva Biotech , Investment Income , Successful Exit , Incubation Portfolio Companies , Will Continue , Incubation Business Through , Investment Funds , North America , Computational Chemistry Department , Faladi Road , Qiantang New District , Supercomputing Center , Chief Executive Officer ,